Boundless Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing extrachromosomal DNA (ecDNA) directed therapeutics (ecDTx) for cancer patients. The company is advancing its ecDTx pipeline targeting ecDNA-driven oncogene amplification, which is associated with aggressive tumor behavior. Boundless Bio aims to identify, develop, and commercialize novel therapies that exploit the unique biology of ecDNA in cancer.
expected 2026-11-27
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-09 | 2025-12-31 | 0001193125-26-097543 | EDGAR | 95K words |
| 2025-03-27 | 2024-12-31 | 0000950170-25-045725 | EDGAR | 92K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-07 | 2026-06-30 | 0001193125-26-339093 | EDGAR | 29K words |
| 2025-11-05 | 2025-09-30 | 0001193125-25-265714 | EDGAR | 31K words |
| 2025-08-05 | 2025-06-30 | 0000950170-25-102391 | EDGAR | 22K words |
| 2025-05-09 | 2025-03-31 | 0000950170-25-067496 | EDGAR | 19K words |
| 2024-11-07 | 2024-09-30 | 0000950170-24-123291 | EDGAR | 20K words |
| 2024-08-12 | 2024-06-30 | 0000950170-24-095421 | EDGAR | 19K words |
| 2024-05-13 | 2024-03-31 | 0000950170-24-058188 | EDGAR | 58K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-28 | 0001193125-26-374787 | EDGAR | 12K words |
| 2026-03-09 | 0001193125-26-097535 | EDGAR | 2K words |
| 2025-11-05 | 0001193125-25-265707 | EDGAR | 2K words |
| 2025-08-05 | 0000950170-25-102386 | EDGAR | 2K words |
| 2025-06-23 | 0000950170-25-089002 | EDGAR | 1K words |
| 2025-05-23 | 0000950170-25-076911 | EDGAR | 2K words |
| 2025-05-09 | 0000950170-25-067495 | EDGAR | 2K words |
| 2025-04-01 | 0001193125-25-070496 | EDGAR | 1K words |
| 2025-03-27 | 0000950170-25-045722 | EDGAR | 2K words |
| 2024-12-12 | 0000950170-24-135768 | EDGAR | 1K words |
29 total filings indexed. 10 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001782303 |
| Ticker | BOLD |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.boundlessbio.com |
| Listed | 2024-03-28 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/BOLD (~200 tokens, structured JSON with cryptographic provenance)